Blueprint Medicines Corp buy Saftman
Start price
30.11.23
/
50%
€64.00
Target price
30.11.24
-
Performance (%)
10.94%
End price
31.01.24
€71.00
Summary
This prediction ended on 31.01.24 with a price of €71.00. The BUY prediction by Saftman finished with a performance of 10.94%. Saftman has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Blueprint Medicines Corp | - | - | - |
| iShares Core DAX® | 0.184% | 5.072% | 8.979% |
| iShares Nasdaq 100 | -0.770% | -2.079% | 26.437% |
| iShares Nikkei 225® | 0.733% | -3.346% | 47.887% |
| iShares S&P 500 | -0.166% | 0.904% | 22.974% |
Comments by Saftman for this prediction
In the thread Blueprint Medicines Corp diskutieren
Saftman hat das Wertpapier Blueprint Medicines Corp in seinem Wikifolio Langfristige Aufwärtstrends gekauft.


